Therapeutic Asset Ratings
443 results matching 1 filter
134,009 assets · 8,804 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
FULVESTRANT
Soft Tissue Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Hyaluronidase zzxf
Ovarian Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Hyaluronidase zzxf
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Hyaluronidase zzxf
Prostate Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Hyaluronidase zzxf
Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Hyaluronidase zzxf
Soft Tissue Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Hyaluronidase zzxf
Ovarian Cancer
OHSU Knight Cancer Institute
Early P1
C
(39)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Soft Tissue Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Irinotecan
Prostate Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Letrozole
Soft Tissue Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Niraparib
Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Niraparib
Soft Tissue Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Olaparib
Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Omo-103
Pancreatic Ductal Adenocarcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Omo-103
Stage II Pancreatic Cancer AJCC v8
OHSU Knight Cancer Institute
Early P1
C
(39)
OXALIPLATIN
Advanced Prostate Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
TRASTUZUMAB
Soft Tissue Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Trastuzumab Emtansine
Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Trastuzumab Emtansine
Soft Tissue Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
VEMURAFENIB
Ovarian Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
VEMURAFENIB
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
VEMURAFENIB
Prostate Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
VEMURAFENIB
Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
VEMURAFENIB
Ovarian Cancer
OHSU Knight Cancer Institute
Early P1
C
(39)
Showing 376 to 400 of 443 assets
Previous
Page 16 of 18
Next
